PARAQUAT-INDUCED LUNG INJURY - PREVENTION BY VASOACTIVE-INTESTINAL-PEPTIDE AND RELATED PEPTIDE HELODERMIN

被引:22
|
作者
PAKBAZ, H [1 ]
FODA, HD [1 ]
BERISHA, HI [1 ]
TROTZ, M [1 ]
SAID, SI [1 ]
机构
[1] VET AFFAIRS MED CTR, NORTHPORT, NY 11768 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1993年 / 265卷 / 04期
关键词
OXIDANT LUNG INJURY; ANTIOXIDANTS; NEUROPEPTIDES;
D O I
10.1152/ajplung.1993.265.4.L369
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We earlier showed that the neuropeptide vasoactive intestinal peptide (VIP) reduces or prevents acute injury produced in rat lungs by xanthine and xanthine oxidase. We have now examined whether VIP can protect against lung injury induced by paraquat, a prooxidant pesticide. Isolated guinea pig lungs were perfused for 60 min with Krebs-4% albumin and mechanically ventilated with 95% 02-5% CO2. Infusion of paraquat (100 mg/kg) into the pulmonary artery (n = 9 observations) increased peak airway pressure from 10.1 +/- 0.6 to 54.7 +/- 6.5 cmH2O, perfusion pressure from 8.0 +/- 0.5 to 14.9 +/- 3.0 cmH2O, wet-to-dry lung weight ratio to 7.17 +/- 0.37, and bronchoalveolar lavage protein content to 2.70 +/- 0.83 mg/ml (P < 0.01). Pretreatment with 1-3 mug.kg-1.min-1 VIP markedly attenuated or prevented all abnormalities. Of the related peptides tested, helodermin was as effective as VIP, but secretin and glucagon were ineffective. The results demonstrate that VIP and helodermin protect perfused guinea pig lungs against paraquat-induced injury and support the view that VIP has antioxidant activity.
引用
收藏
页码:L369 / L373
页数:5
相关论文
共 50 条
  • [1] VASOACTIVE-INTESTINAL-PEPTIDE
    SAID, SI
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1986, 9 (02) : 191 - 200
  • [2] VASOACTIVE-INTESTINAL-PEPTIDE ENHANCES LUNG PRESERVATION
    ALESSANDRINI, F
    THAKKAR, M
    FODA, HD
    SAID, SI
    LODI, R
    PAKBAZ, H
    SCHRAUFNAGEL, DE
    TRANSPLANTATION, 1993, 56 (04) : 964 - 973
  • [3] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) PROTECTS THE LUNG AGAINST OXIDANT INJURY
    BERISHA, H
    FODA, HD
    PAKBAZ, H
    SHARAF, H
    TROTZ, M
    SAID, SI
    CIRCULATION, 1992, 86 (04) : 354 - 354
  • [4] VASOACTIVE-INTESTINAL-PEPTIDE AND HELODERMIN INHIBIT PHOSPHOLIPASE-A(2) ACTIVITY IN-VITRO
    TROTZ, ME
    SAID, SI
    REGULATORY PEPTIDES, 1993, 48 (03) : 301 - 307
  • [5] VASOACTIVE-INTESTINAL-PEPTIDE (VIP) MODULATES INJURY CAUSED BY PARAQUAT IN GUINEA-PIG LUNGS
    PAKBAZ, H
    FODA, HD
    BERISHA, HI
    SAID, SI
    CLINICAL RESEARCH, 1990, 38 (02): : A440 - A440
  • [6] VASOACTIVE-INTESTINAL-PEPTIDE - A CHRONOIMMUNOMODULATOR
    GUGINI, P
    LUCIA, P
    DIPALMA, L
    POZZILLI, P
    RE, M
    CANOVA, R
    GASBARRONE, L
    CIANETTI, A
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 46 (02): : 274 - 276
  • [7] VASOACTIVE-INTESTINAL-PEPTIDE PROTECTS AGAINST LUNG INJURY DUE TO ACID ASPIRATION
    IWANAGA, T
    FODA, HD
    LIU, LW
    SAID, SI
    CLINICAL RESEARCH, 1987, 35 (03): : A661 - A661
  • [8] HUMAN SMALL-CELL LUNG-CARCINOMA - INHIBITION OF GROWTH BY VASOACTIVE-INTESTINAL-PEPTIDE (VIP) AND HELODERMIN (HD)
    MARUNO, K
    SAID, SI
    CLINICAL RESEARCH, 1991, 39 (02): : A225 - A225
  • [9] VASOACTIVE-INTESTINAL-PEPTIDE PREVENTS LUNG INJURY DUE TO XANTHINE XANTHINE-OXIDASE
    BERISHA, H
    FODA, H
    SAKAKIBARA, H
    TROTZ, M
    PAKBAZ, H
    SAID, SI
    AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02): : L151 - L155
  • [10] TRANSMITTER ROLE OF VASOACTIVE-INTESTINAL-PEPTIDE
    FAHRENKRUG, J
    PHARMACOLOGY & TOXICOLOGY, 1993, 72 (06): : 354 - 363